Tsai CY - Search Results

1

Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer.

Wenzel AT, Champa D, Venkatesh H, Sun S, Tsai CY, Mesirov JP, Bui JD, Howell SB, Harismendy O. Wenzel AT, et al. Among authors: tsai cy. NPJ Syst Biol Appl. 2022 Jun 17;8(1):20. doi: 10.1038/s41540-022-00230-z. NPJ Syst Biol Appl. 2022. PMID: 35715421 Free PMC article.

2

Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling.

Tsai CY, Finley JC, Ali SS, Patel HH, Howell SB. Tsai CY, et al. Biochem Pharmacol. 2012 Oct 15;84(8):1007-13. doi: 10.1016/j.bcp.2012.07.014. Epub 2012 Jul 25. Biochem Pharmacol. 2012. PMID: 22842628 Free PMC article.

3

Characterization of a monoclonal antibody capable of reliably quantifying expression of human Copper Transporter 1 (hCTR1).

Quail JF, Tsai CY, Howell SB. Quail JF, et al. Among authors: tsai cy. J Trace Elem Med Biol. 2014 Apr;28(2):151-159. doi: 10.1016/j.jtemb.2013.12.003. Epub 2013 Dec 18. J Trace Elem Med Biol. 2014. PMID: 24447817 Free PMC article.

4

Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4.

Tsai CY, Larson CA, Safaei R, Howell SB. Tsai CY, et al. Biochem Pharmacol. 2014 Aug 15;90(4):379-87. doi: 10.1016/j.bcp.2014.06.019. Epub 2014 Jun 23. Biochem Pharmacol. 2014. PMID: 24967972 Free PMC article.

5

The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2).

Tsai CY, Liebig JK, Tsigelny IF, Howell SB. Tsai CY, et al. Metallomics. 2015 Nov;7(11):1477-87. doi: 10.1039/c5mt00131e. Epub 2015 Jul 24. Metallomics. 2015. PMID: 26205368 Free PMC article.

6

Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.

Bompiani KM, Tsai CY, Achatz FP, Liebig JK, Howell SB. Bompiani KM, et al. Among authors: tsai cy. Metallomics. 2016 Sep 1;8(9):951-62. doi: 10.1039/c6mt00076b. Epub 2016 May 9. Metallomics. 2016. PMID: 27157188 Free PMC article.

7

APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency.

Tsai CY, Sun S, Zhang H, Local A, Su Y, Gross LA, Rice WG, Howell SB. Tsai CY, et al. Mol Cancer Ther. 2018 Jun;17(6):1167-1176. doi: 10.1158/1535-7163.MCT-17-0834. Epub 2018 Apr 6. Mol Cancer Ther. 2018. PMID: 29626126 Free PMC article.

8

APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells.

Local A, Zhang H, Benbatoul KD, Folger P, Sheng X, Tsai CY, Howell SB, Rice WG. Local A, et al. Among authors: tsai cy. Mol Cancer Ther. 2018 Jun;17(6):1177-1186. doi: 10.1158/1535-7163.MCT-17-1209. Epub 2018 Apr 6. Mol Cancer Ther. 2018. PMID: 29626127

9

A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis.

Tsai CY, Saito T, Sarangdhar M, Abu-El-Haija M, Wen L, Lee B, Yu M, Lipata DA, Manohar M, Barakat MT, Contrepois K, Tran TH, Theoret Y, Bo N, Ding Y, Stevenson K, Ladas EJ, Silverman LB, Quadro L, Anthony TG, Jegga AG, Husain SZ. Tsai CY, et al. Sci Transl Med. 2023 Mar 15;15(687):eabn2110. doi: 10.1126/scitranslmed.abn2110. Epub 2023 Mar 15. Sci Transl Med. 2023. PMID: 36921036 Free PMC article.

10

6-Gingerol Induced Apoptosis and Cell Cycle Arrest in Glioma Cells via MnSOD and ERK Phosphorylation Modulation.

Lim SW, Chen WC, Ko HJ, Su YF, Wu CH, Huang FL, Li CF, Tsai CY. Lim SW, et al. Among authors: tsai cy. Biomol Ther (Seoul). 2024 Dec 5. doi: 10.4062/biomolther.2024.084. Online ahead of print. Biomol Ther (Seoul). 2024. PMID: 39632791 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,341 results

Search Page

Filters